Proud to share our new review on membrane-modified lipid nanoparticles for RNA delivery. We discuss strategies to overcome the liver-centric delivery of LNPs and enable broader therapeutic applications of RNA.
Excited to contribute to this with @elisehoover and @TheDayLab
Hot off the press! Fantastic review of "Membrane-modified lipid nanoparticles for RNA delivery" in Molecular Therapy Methods & Clinical Development, written by @TheDayLab members @RoyChitran and @elisehoover. https://t.co/8wT6XtbZY3
I'm honored to share that I am being promoted to Professor. This milestone represents years of dedication to conducting impactful research, teaching, and service. Thank you to my mentors, mentees, students, colleagues, and family who have been part of this journey! Hooray!
New @TheDayLab research led by @EricSterin now published in RSC Pharmaceutics! Important insights for those who use lipophilic dyes to label nanoparticles for cellular uptake and biodistribution studies. https://t.co/WSlfgXsmn2
About a month after Donald Trump took office, almost all grant-review meetings remain suspended at the US National Institutes of Health, preventing the world’s largest public funder of biomedical research from spending much of its US$47 billion annual budget.
https://t.co/DoVvF0MIsK
@PatMcAfeeShow#IDontWantToOverreactBUT How is Wolf still the GM of the Patriots? He is the one who made Jerod in this position with a bad team! Wolf should be fired too, or am I overreacting?